The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
L‐asparaginase treatment in acute lymphoblastic leukemia: A focus on Erwinia asparaginase
Open accessAbstract
Asparaginases are a cornerstone of treatment protocols for acute lymphoblastic leukemia (ALL) and are used for remission induction and intensification treatment in all pediatric regimens and in the majority of adult treatment protocols. Extensive clinical data have shown that intensive asparaginase treatment improves clinical outcomes in childhood ALL. Three asparaginase preparations are available: the native asparaginase derived from Escherichia coli (E. coli asparaginase), a pegylated form of this enzyme (PEG-asparaginase), and a product isolated from Erwinia chrysanthemi, ie, Erwinia asparaginase. Clinical hypersensitivity reactions and silent inactivation due to antibodies against E. coli asparaginase, lead to inactivation of E. coli asparaginase in up to 60% of cases. Current treatment protocols include E. coli asparaginase or PEG-asparaginase for first-line treatment of ALL. Typically, patients exhibiting sensitivity to one formulation of asparaginase are switched to another to ensure they receive the most efficacious treatment regimen possible. Erwinia asparaginase is used as a second- or third-line treatment in European and US protocols. Despite the universal inclusion of asparaginase in such treatment protocols, debate on the optimal formulation and dosage of these agents continues. This article provides an overview of available evidence for optimal use of Erwinia asparaginase in the treatment of ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depletion of plasma asparagine by a recombinant form of bacterial L-Asparaginase is an effective anticancer intervention for this cancer type (Hill et al., 1967; Pieters et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Pieters et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Summary of product characteristics
(2013) · Pharmaceutical Medicine · doi:10.1093/med/9780199609147.003.0027 · Cited by 1,918
Pui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationTreating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationSilverman, L. B. (2001) · Blood · doi:10.1182/blood.v97.5.1211 · Cited by 869
Self-citationArmstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Kantarjian, H. M., Thomas, D. A., O'Brien, S. M., Cortes, J. E., Giles, F. J., Jeha, S., Bueso-Ramos, C., Pierce, S. A., Shan, J., Koller, C. A., et al. (2004) · Cancer · doi:10.1002/cncr.20668 · Cited by 638
Möricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dördelmann, M., Löning, L., Beier, R., Ludwig, W.-D., Ratei, R., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112920 · Cited by 611
Self-citationBoissel, N., Auclerc, M.-F., Lhéritier, V., Pérel, Y., Thomas, X., Leblanc, T. M., Rousselot, P. H., Cayuela, J., Gabert, J. A., Fegueux, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.053 · Cited by 606
Self-citationAvramis, V. I., Sencer, S., Periclou, A. P., Sather, H. N., Bostrom, B., Cohen, L. J., Ettinger, A. G., Ettinger, L. J., Franklin, J. L., Gaynon, P. S., et al. (2002) · Blood · doi:10.1182/blood.v99.6.1986 · Cited by 492
Pui, C., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B. I., Howard, S. C., Hudson, M. M., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1616 · Cited by 461
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Pui, C., Yang, J. J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A. J., Baruchel, A., Silverman, L. B., Schmiegelow, K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1636 · Cited by 1,016
Self-citationSurviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells
Wortel, I. M. N., van der Meer, L. T., Kilberg, M. S., & van Leeuwen, F. N. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.07.003 · Cited by 630
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 501
Self-citationMäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 454
A 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.06.007 · Cited by 368
Self-citationPieters, R., de Groot‐Kruseman, H., van der Velden, V., Fiocco, M. F., van den Berg, H., de Bont, E., Egeler, R. M., Hoogerbrugge, P. M., Kaspers, G. J. L., van der Schoot, C. E., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.6364 · Cited by 366
Self-citationL-asparaginase in the treatment of patients with acute lymphoblastic leukemia
Egler, R. A., Ahuja, S. P., & Matloub, Y. (2016) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.184769 · Cited by 334
Role of glutamine and interlinked asparagine metabolism in vessel formation
Huang, H., Vandekeere, S., Kalucka, J., Bierhansl, L., Zecchin, A., Brüning, U., Visnagri, A., Yuldasheva, N., Goveia, J., Cruys, B., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695518 · Cited by 320
Asparagine synthetase: Function, structure, and role in disease
Lomelino, C. L., Andring, J. T., McKENNA, R. V., & Kilberg, M. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.819060 · Cited by 309
Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
Hijiya, N., & van der Sluis, I. M. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1101098 · Cited by 291
Amino Acid Depletion Therapies: Starving Cancer Cells to Death
Butler, M., van der Meer, L. T., & van Leeuwen, F. N. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.03.003 · Cited by 277
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Directed Evolution of Enzymes for Industrial Biocatalysis
Porter, J. L., Rusli, R. A., & Ollis, D. L. (2015) · ChemBioChem · doi:10.1002/cbic.201500280 · Cited by 247
van der Sluis, I. M., Vrooman, L. M., Pieters, R., Baruchel, A., Escherich, G., Goulden, N., Mondelaers, V., de Toledo, J. S., Rizzari, C., Silverman, L. B., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.137380 · Cited by 247
Self-citationMetabolic rearrangements in primary liver cancers: cause and consequences
Satriano, L., Lewińska, M., Rodrigues, P. M., Bañales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 245
Place, A. E., Stevenson, K. E., Vrooman, L. M., Harris, M. H., Hunt, S. K., O’Brien, J. E., Supko, J. G., Asselin, B. L., Athale, U. H., Clavell, L. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00363-0 · Cited by 242
Self-citationRecent developments in l-asparaginase discovery and its potential as anticancer agent
Shrivastava, A., Khan, A. A., Khurshid, M., Kalam, M. A., Jain, S. K., & Singhal, P. K. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.01.002 · Cited by 238
Blackman, L. D., Varlas, S., Arno, M. C., Houston, Z. H., Fletcher, N. L., Thurecht, K. J., Hasan, M., Gibson, M. I., & O’Reilly, R. K. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00168 · Cited by 227
Tong, W. H., Pieters, R., Kaspers, G. J. L., Loo, D. M. W. M. T., Bierings, M., van den Bos, C., Kollen, W. J. W., Hop, W. C. J., Lanvers‐Kaminsky, C., Relling, M. V., et al. (2014) · Blood · doi:10.1182/blood-2013-10-534347 · Cited by 225
Self-citationDietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 213
Anticancer Activity of Bacterial Proteins and Peptides
Karpiński, T. M. M., & Adamczak, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020054 · Cited by 202
Gupta, S., Wang, C., Raetz, E. A., Schore, R. J., Salzer, W. L., Larsen, E. C., Maloney, K. W., Mattano, L. A., Carroll, W. L., Winick, N. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03024 · Cited by 193
Self-citationBrumano, L. P., da Silva, F. V. S., Costa-Silva, T. A., Apolinário, A. C., Santos, J. H. P. M., Kleingesinds, E. K., Monteiro, G., Rangel‐Yagui, C. D. O., Benyahia, B., & Pessoa, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00212 · Cited by 189
Asparaginase pharmacokinetics and implications of therapeutic drug monitoring
Asselin, B. L., & Rizzari, C. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.1003056 · Cited by 187
Self-citationIncreased Oxidative Stress as a Selective Anticancer Therapy
Liu, J., & Wang, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/294303 · Cited by 191
Modeling cancer metabolism on a genome scale
Yizhak, K., Chaneton, B., Gottlieb, E., & Ruppin, E. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145307 · Cited by 187
A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
Qiu, Y., Cai, G., Zhou, B., Li, D., Zhao, A., Xie, G., Li, H., Cai, S., Xie, D., Huang, C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1939 · Cited by 182
Cancer drug resistance: redox resetting renders a way
Liu, Y., Li, Q., Zhou, L., Xie, N., Nice, E. C., Zhang, H., Huang, C., & Lei, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8600 · Cited by 182
Bolzoni, M., Chiu, M., Accardi, F., Vescovini, R., Airoldi, I., Storti, P., Todoerti, K., Agnelli, L., Missale, G., Andreoli, R., et al. (2016) · Blood · doi:10.1182/blood-2016-01-690743 · Cited by 177
Drug-induced amino acid deprivation as strategy for cancer therapy
Fung, M. K. L., & Chan, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0509-9 · Cited by 172
Recent Advances in Anti-cancer Protein/Peptide Delivery
Liu, X., Wu, F., Ji, Y. I., & Yin, L. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00750 · Cited by 163
Qeshmi, F. I., Homaei, A. A., Fernandes, P. C. D. B., & Javadpour, S. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.01.011 · Cited by 157
Therapeutic l -asparaginase: upstream, downstream and beyond
Lopes, A. M., Nascimento, L. D. O., Ribeiro, A., Tairum, C. A., Breyer, C. A., de Oliveira, M. A., Monteiro, G., de Souza‐Motta, C. M., Magalhães, P. O., Farías, J. G., et al. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1120705 · Cited by 155
Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 154
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
Trimpont, M. V., Peeters, E., Visser, Y. D., Schalk, A. M., Mondelaers, V., Moerloose, B. D., Lavie, A., Lammens, T., Goossens, S., & Vlierberghe, P. V. (2022) · Cancers · doi:10.3390/cancers14040902 · Cited by 143
Li, X., Cui, Y., Sun, Z., Zhang, L., Li, L., Wang, X., Wu, J., Fu, X., Ma, W., Zhang, X., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0153 · Cited by 138
Lauschke, V. M., Zhou, Y., & Ingelman‐Sundberg, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.002 · Cited by 135
Sharifi, M., Sohrabi, M. J., Hosseinali, S. H., Hasan, A., Kani, P. H., Talaei, A. J., Karim, A., Nanakali, N. M. Q., Salihi, A. B., Aziz, F. M., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.064 · Cited by 135
Truelove, E., Fielding, A. K., & Hunt, B. J. (2012) · Leukemia · doi:10.1038/leu.2012.290 · Cited by 133
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
Anreddy, N., Gupta, P., Kathawala, R. J., Patel, A. S., Wurpel, J. N. D., & Chen, Z. (2014) · Molecules · doi:10.3390/molecules190913848 · Cited by 126
Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines
Parmentier, J. H., Maggi, M., Tarasco, E., Scotti, C., Avramis, V. I., & Mittelman, S. D. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.008 · Cited by 114
Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia
Salzer, W. L., Bostrom, B., Messinger, Y. H., Perissinotti, A. J., & Marini, B. L. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1386305 · Cited by 111
The Pleiotropic Effects of Glutamine Metabolism in Cancer
Bott, A. J., Maimouni, S., & Zong, W. (2019) · Cancers · doi:10.3390/cancers11060770 · Cited by 111
A Dual Functional Nanoreactor for Synergistic Starvation and Photodynamic Therapy
Zhu, Y., Shi, H., Li, T., Yu, J., Guo, Z., Cheng, J., & Liu, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01039 · Cited by 112
Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells
Song, P., Ye, L., Fan, J., Li, Y., Zeng, X. L., Wang, Z., Wang, S., Zhang, G., Yang, P., Cao, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2869 · Cited by 109
Husain, I., Sharma, A., Kumar, S. G., & Malik, F. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148877 · Cited by 109
Jia, M., Xu, M., He, B., & Rao, Z. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf402636w · Cited by 108
Insights into function and evolution of parasitoid wasp venoms
Poirié, M., Colinet, D., & Gatti, J. (2014) · Current Opinion in Insect Science · doi:10.1016/j.cois.2014.10.004 · Cited by 107
Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia
Kloos, R. Q. H., Pieters, R., Jumelet, F. M. V., de Groot‐Kruseman, H. A., van den Bos, C., & van der Sluis, I. M. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02292 · Cited by 106
Self-citationChand, S., Mahajan, R. V., Prasad, J. P., Sahoo, D. K., Mihooliya, K. N., Dhar, M. S., & Sharma, G. D. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1888 · Cited by 106
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
Hampton, M. B., Vick, K. A., Skoko, J., & Neumann, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7422 · Cited by 103
Translational reprogramming marks adaptation to asparagine restriction in cancer
Pathria, G., Lee, J. S., Hasnis, E., Tandoc, K. V., Scott, D. A., Verma, S. K., Feng, Y., Larue, L., Sahu, A. D., Topisirović, I., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0415-1 · Cited by 103
Circumventing the side effects of L-asparaginase
Fonseca, M. H. G., Fiúza, T. D. S., de Morais, S. B., de Souza, T. D. A. C. B., & Trevizani, R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111616 · Cited by 101
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Maese, L. D., & Rau, R. E. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.902117 · Cited by 99
Recent Research Advances in Childhood Acute Lymphoblastic Leukemia
Pui, C. (2010) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(10)60123-4 · Cited by 99
Self-citationA critical review on properties and applications of microbial l -asparaginases
Krishnapura, P. R., Belur, P. D., & Subramanya, S. B. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1022505 · Cited by 94
Optimizing asparaginase therapy for acute lymphoblastic leukemia
Rizzari, C., Conter, V., Starý, J., Colombini, A., Moericke, A., & Schrappe, M. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835d7d85 · Cited by 93
Self-citationNanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Ma, M., Zhang, Y., Pu, K., & Tang, W. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 100
Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections
Fernandes, H. S., Teixeira, C. S. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1254194 · Cited by 91
L-asparaginase production review: bioprocess design and biochemical characteristics
Castro, D., Marques, A. S. C., Almeida, M. R., de Paiva, G. B., Bento, H. B. S., Pedrolli, D. B., Freire, M. G., Tavares, A. P. M., & Santos‐Ebinuma, V. C. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11359-y · Cited by 90
Liang, S., Liu, Y., Jin, X., Liu, G., Wen, J., Zhang, L., Li, J., Yuan, X., Chen, I. S. Y., Chen, W., et al. (2016) · Nano Research · doi:10.1007/s12274-016-0991-3 · Cited by 91
Ateş, B., Ulu, A., Köytepe, S., Noma, S. A. A., Kolat, V. S., & İzgi, T. (2018) · RSC Advances · doi:10.1039/c8ra06346j · Cited by 88
Costa, I. M., Schultz, L., Pedra, B. D. A. B., Leite, M. S. M., Farsky, S. H. P., de Oliveira, M. A., Pessoa, A., & Monteiro, G. (2016) · Scientific Reports · doi:10.1038/srep36239 · Cited by 87
Frandsen, T. L., Heyman, M. M., Abrahamsson, J., Vettenranta, K. K., Åsberg, A. E., Vaitkevičienė, G. E., Pruunsild, K., Toft, N., Birgens, H., Hallböök, H., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.027 · Cited by 84
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia
Burke, M. J. (2014) · Future Oncology · doi:10.2217/fon.14.138 · Cited by 84
Salzer, W. L., Asselin, B. L., Supko, J. G., Devidas, M., Kaiser, N. A., Plourde, P. V., Winick, N. J., Reaman, G. H., Raetz, E. A., Carroll, W. L., et al. (2013) · Blood · doi:10.1182/blood-2013-01-480822 · Cited by 81
Self-citationEl‐Naggar, N. E., El-Ewasy, S. M., & El-Shweihy, N. M. (2014) · International Journal of Pharmacology · doi:10.3923/ijp.2014.182.199 · Cited by 81
Rank, C. U., Wolthers, B. O., Grell, K., Albertsen, B. K., Frandsen, T. L., Overgaard, U. M., Toft, N., Nielsen, O. J., Wehner, P. S., Harila‐Saari, A. H., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.02208 · Cited by 81
PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol
Henriksen, L. T., Harila‐Saari, A. H., Ruud, E., Abrahamsson, J., Pruunsild, K., Vaitkevičienė, G. E., Jónsson, Ó. G., Schmiegelow, K., Heyman, M. M., Schrøder, H. D., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25319 · Cited by 80
Ultrasound-propelled nanowire motors enhance asparaginase enzymatic activity against cancer cells
Uygun, M., Jurado‐Sánchez, B., Uygun, D. A., Singh, V. V., Zhang, L., & Wang, J. (2017) · Nanoscale · doi:10.1039/c7nr07396h · Cited by 80
Korotchkina, L. G., Kazyulkin, D. N., Komarov, P. G., Polinsky, A., Andrianova, E. L., Joshi, S. P., Gupta, M., Vujcic, S., Kononov, E., Toshkov, I. A., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0692-5 · Cited by 81
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways
Kim, S. M., Roy, S. G., Chen, B., Nguyen, T. M., McMonigle, R. J., McCracken, A. N., Zhang, Y., Kofuji, S., Hou, J., Selwan, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87148 · Cited by 77
Kullas, A. L., McClelland, M., Yang, H., Tam, J. W., Torres, A., Porwollik, S., Mena, P., McPhee, J. B., Bogomolnaya, L. M., Andrews‐Polymenis, H. L., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.018 · Cited by 77
Recent research progress on microbial l-asparaginases
Zuo, S., Zhang, T., Jiang, B., & Mu, W. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6271-9 · Cited by 75
Tumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 78
Dias, F. F. G., Ruiz, A. L. T. G., Torre, A. D., & Sato, H. H. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2016.07.007 · Cited by 72
Bacterial l ‐asparaginases for cancer therapy: Current knowledge and future perspectives
Ghasemian, A., AL-Marzoqi, A. H., Al-Abodi, H. R., Alghanimi, Y. K., Kadhum, S. A., Mostafavi, S. K. S., & Fattahi, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28563 · Cited by 68
l -asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia
Kumar, K., Kaur, J., Walia, S., Pathak, T., & Aggarwal, D. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.803224 · Cited by 69
Klaassen, I. L. M., Lauw, M. N., Fiocco, M. F., van der Sluis, I. M., Pieters, R., Middeldorp, S., van de Wetering, M. D., de Groot‐Kruseman, H. A., & van Ommen, C. H. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12182 · Cited by 68
Self-citationImproving the Treatment of Acute Lymphoblastic Leukemia
Radadiya, A., Zhu, W., Coricello, A., Alcaro, S., & Richards, N. G. J. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00354 · Cited by 73
Wolthers, B. O., Frandsen, T. L., Abrahamsson, J., Albertsen, B. K., Helt, L. R., Heyman, M. M., Jónsson, Ó. G., Kõrgvee, L. T., Lund, B., Raja, R. A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.203 · Cited by 68
Ulu, A., Noma, S. A. A., Köytepe, S., & Ateş, B. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1478422 · Cited by 66
Asparaginase: an old drug with new questions
Cecconello, D. K., Magalhães, M. R., Werlang, I. C. R., Lee, M. L. D. M., Michalowski, M. B., & Daudt, L. E. (2019) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2019.07.010 · Cited by 65
Lauritano, C., Luca, D. D., Ferrarini, A., Avanzato, C., Minio, A., Esposito, F., & Ianora, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12092-1 · Cited by 66
Safety profile of asparaginaseErwinia chrysanthemiin a large compassionate‐use trial
Plourde, P. V., Jeha, S., Hijiya, N., Keller, F. G., Silverman, L. B., Rheingold, S. R., Dreyer, Z. E., Dahl, G. V. H., Mercedes, T., Lai, C., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24938 · Cited by 64
Self-citationDevelopment of asparaginaseErwinia chrysanthemifor the treatment of acute lymphoblastic leukemia
Salzer, W. L., Asselin, B. L., Plourde, P. V., Corn, T., & Hunger, S. P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12496 · Cited by 64
Self-citationMetabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 63
Targeting Redox Metabolism in Pancreatic Cancer
Hadi, N. A., Reyes‐Castellanos, G., & Carrier, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041534 · Cited by 63
Mezzano, V., Junior, P. F. G.-B., Picard, M., Caiado, J., & Castells, M. (2013) · BioDrugs · doi:10.1007/s40259-013-0066-x · Cited by 63
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy
Mei, L., Ontiveros, E. P., Griffiths, E. A., Thompson, J. E., Wang, E. S., & Wetzler, M. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.01.001 · Cited by 63
Therapeutic proteins: developments, progress, challenges, and future perspectives
Kumar, V., Barwal, A., Sharma, N., Mir, D. S., Kumar, P., & Kumar, V. (2024) · 3 Biotech · doi:10.1007/s13205-024-03958-z · Cited by 62
Optimization and purification of l -asparaginase from fungi: A systematic review
Souza, P. M., de Freitas, M. M., Cardoso, S. L., Pessoa, A., Guerra, E. N. S., & Magalhães, P. O. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.006 · Cited by 62
Boissel, N., & Sender, L. S. (2015) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2015.0014 · Cited by 61
Asparaginase pharmacology: challenges still to be faced
Lanvers‐Kaminsky, C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3236-y · Cited by 61
Radha, R., Arumugam, N., & Gummadi, S. N. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.165 · Cited by 61
Finch, E. R., Smith, C. A., Yang, W., Liu, Y., Kornegay, N. M., Panetta, J. C., Crews, K. R., Molinelli, A. R., Cheng, C., Pei, D., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28040 · Cited by 58
Self-citationPradhan, B., Dash, S. K., & Sahoo, S. (2013) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60182-3 · Cited by 57
Metadata
- Authors
- Pieters, R., Hunger, S. P., Boos, J., Rizzari, C., Silverman, L., Baruchel, A., Goekbuget, N., Schrappe, M., & Pui, C.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Children's Hospital Colorado (US)
- University of Münster (DE)
- Azienda Ospedaliera San Gerardo (IT)
- Boston Children's Hospital (US)
- University Hospital Frankfurt (DE)
- University Hospital Schleswig-Holstein (DE)
- Corresponding author
- Pieters, Rob
- Pui, Ching‐Hon
- ORCID
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-09-07
- Volume
- 117
- Issue
- 2
- Pages
- 238-249
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- PMC
- PMC3000881
- OpenAlex
- W1965542498
- Cited by
- 569
- References
- 74
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 35 · 2023: 38 · 2022: 49 · 2021: 53 · 2020: 56 · 2019: 43 · 2018: 41 · 2017: 41 · 2016: 39 · 2015: 37 · 2014: 42 · 2013: 28 · 2012: 18
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- National Cancer Institute (CA21765, P01CA020180, P30CA021765)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- L-asparaginase, acute lymphoblastic leukemia, PEG-asparaginase, pediatric leukemia, treatment protocols, dose optimization
- MeSH terms
- Asparaginase, Drug Combinations, Drug Hypersensitivity, Erwinia, Humans, Spironolactone, Sulfonamides, Drug Monitoring, Precursor Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
